会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • 2,2-di-substituted benzopyran leukotriene-D.sub.4 antagonists
    • 2,2-二取代苯并吡喃白三烯-D4拮抗剂
    • US5219883A
    • 1993-06-15
    • US790976
    • 1991-11-12
    • Francis J. KoszykJames R. Deason
    • Francis J. KoszykJames R. Deason
    • C07D311/22C07D311/58
    • C07D311/58C07D311/22
    • This invention relates to LTD.sub.4 antagonists of the formula: ##STR1## or pharmaceutically acceptable salts thereof, wherein R.sup.1 is methyl, phenyl, ##STR2## wherein X.sub.1 and X.sub.2 may be the same or different and are members of the group consisting of hydrogen, --Cl, --Br, --CF.sub.3, --NH.sub.2, --NO.sub.2, or alkyl of 1-3 carbon atoms; m is 1 to 9; n is 1 to 5; V is --CH(OH)--, or --CH.sub.2 --; W is hydrogen or alkyl of 1-6 carbon atoms; Y is hydrogen or --COCH.sub.3 provided that when W is hydrogen Y is not hydrogen; both Z moieties are --CHO, --COOR.sup.2, --COR.sup.3, --CH(OR.sup.4)--CH.sub.2 OR.sup.4, or CH.sub.2 OR.sup.4 with the exception that when one Z moiety of Formula I is COOR.sup.2, the other Z moiety may be COR.sup.3 ;R.sup.2 is hydrogen, a pharmaceutically acceptable cation, straight or branched chain alkyl having 1-6 carbon atoms, --CH.sub.2 --CH(OR.sup.5)--CH.sub.2 --OR.sup.5, CH(CH.sub.2 OR.sup.5).sub.2 with the proviso that when Z is --COOR.sup.2, the R.sup.2 substituent in one --COOR.sup.2 moiety may be the same or different from the R.sup.2 substituent in the other COOR.sup.2 moiety;R.sup.3 is --NR.sup.7 R.sup.8 wherein R.sup.7 and R.sup.8 may be the same or different and are members of the group comprising hydrogen or alkyl having 1-6 carbon atoms;R.sup.4 is hydrogen, or --C(O)--R.sup.6 ;R.sup.5 is hydrogen, benzyl-, or alkyl or 1-3 carbon atoms; andR.sup.6 is alkyl of 1-6 carbon atoms.
    • 本发明涉及下式的LTD4拮抗剂或其药学上可接受的盐,其中R 1是甲基,苯基,其中X 1和X 2可以相同或不同,并且是下列成员: 的氢,-Cl,-Br,-CF 3,-NH 2,-NO 2或1-3个碳原子的烷基; m为1〜9; n为1至5; V是-CH(OH) - 或-CH 2 - ; W是氢或1-6个碳原子的烷基; Y是氢或-COCH 3,条件是当W是氢时,Y不是氢; 两个Z部分都是-CHO,-COOR 2,-COR 3,-CH(OR 4)-CH 2 OR 4或CH 2 OR 4,除了当式I的一个Z部分是COOR 2时,另一个Z部分可以是COR 3; R2是氢,可药用阳离子,具有1-6个碳原子的直链或支链烷基,-CH2-CH(OR5)-CH2-OR5,CH(CH2OR5)2,条件是当Z是-COOR2时,R2 一个-COOR 2部分中的取代基可以与其它COOR 2部分中的R 2取代基相同或不同; R 3是-NR 7 R 8,其中R 7和R 8可以相同或不同,并且是包含氢或具有1-6个碳原子的烷基的基团的成员; R4是氢或-C(O)-R6; R5是氢,苄基或烷基或1-3个碳原子; R6是1-6个碳原子的烷基。
    • 9. 发明授权
    • Azabicycloalkyl and azatricycloalkyl amides
    • 偶氮二环烷基和氮杂环烷基酰胺
    • US5198435A
    • 1993-03-30
    • US669543
    • 1991-03-14
    • Richard A. MuellerRichard A. PartisJames R. Deason
    • Richard A. MuellerRichard A. PartisJames R. Deason
    • C07D295/185C07D453/02
    • C07D295/185C07D453/02
    • The compounds of this invention are bicyclic, tricyclic, azabicyclic and azatricyclic amides represented by the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different members of the group consisting of halo, phenyl, substituted phenyl and a ##STR2## group wherein n, m and p are independently an integer of from 1 to 8 provided than n+m+p is equal to or less than 10; x is thio, sulfinyl or sulfonyl; Alk is straight or branched chain lower alkylene; R.sub.3 is selected from the group consisting of a bicycloalkylamino, tricycloalkylamino, azabicycloalkyl, azatricycloalkyl, azabicycloalkylamino, azatricycloalkylamino or dicycloalkylamino. The compounds are useful as anti-inflammatory and anti-allergy agents.
    • 本发明的化合物是由下式表示的双环,三环,氮杂双环和氮杂三环酰胺:其中:R 1和R 2是由卤素,苯基,取代的苯基和取代的苯基组成的组中相同或不同的成员 其中n,m和p独立地为n + m + p等于或小于10提供的1至8的整数; x是硫代,亚磺酰基或磺酰基; Alk是直链或支链低级亚烷基; R 3选自二环烷基氨基,三环烷基氨基,氮杂双环烷基,氮杂环烷基,氮杂双环烷基氨基,氮杂三环烷基氨基或二环烷基氨基。 该化合物可用作抗炎和抗过敏剂。